Abstract: Hypertension is a major risk factor leading to devastating cardiovascular events such as myocardial infarction, stroke, heart failure, and renal failure. Despite intensive research in this area, mechanisms underlying essential hypertension remain to be defined. Accumulating evidence indicates that neural components including both sympathetic and sensory nerves innervating the cardiovascular and renal tissues play a key role in regulating water and sodium homeostasis and blood pressure, and that abnormalities in these nervous systems contribute to increased salt sensitivity and development of hypertension. In contrast to relatively well-defined sympathetic nervous system, the role of sensory nerves in the control of cardiovascular homeostasis is largely unknown. Data from our laboratory show that degeneration of capsaicinsensitive sensory nerves renders a rat salt sensitive in terms of blood pressure regulation. Evidence is also available indicating that sensory nerves, in interacting with other neurohormonal systems including the sympathetic nervous system, the renin-angiotensin aldosterone system, the endothelin system, and superoxide, regulate cardiovascular and renal function in such that they play a counter-balancing role in preventing salt-induced increases in blood pressure under pathophysiological conditions. Altered activity of the sensory nervous system, a condition existed in both genetic and experimental models of hypertension, contributes to the development of hypertension. This article focuses on reviewing the current knowledge regarding the possible role of sensory nerves in regulating blood pressure homeostasis as well as the function and regulation of novel molecules expressed in sensory nerves.
INTRODUCTION
Hypertension is one of the most important risk factors for the development of cardiovascular disease [1] , including coronary artery disease, stroke, left ventricular hypertrophy, heart failure, and renal insufficiency and end-stage kidney disease. Despite decades of intensive research into the mechanisms responsible for hypertension, there is still no consensus regarding the underlying defects or even the sequence of hemodynamic events leading to hypertension. Increased dietary sodium has long been implicated in the pathogenesis of hypertension [2] . It is well established that subjects taking very high dietary sodium have a much greater incidence of hypertension than those consuming a low sodium diet [3] . Although animals models of saltdependent hypertension have been developed, including genetic, pharmacological, and surgically induced models [4] , the mechanistic link between dietary salt and hypertension remains poorly understood.
Accumulating evidence indicates that neural components especially sympathetic nerves innervating the cardiovascular and renal tissues play a key role in regulating water and sodium homeostasis and blood pressure, and that abnormalities in this nervous system contribute to increased salt sensitivity and development of hypertension. In contrast to relatively well-defined sympathetic nervous system, the role of sensory *Address correspondence to this author at the Department of Medicine, B316 Clinical Center, Michigan State University, East Lansing, MI 48824, USA; Tel: 517-432-0797; Fax: 517-432-1326; E-mail: donna.wang@ht.msu.edu nerves in the control of cardiovascular homeostasis is largely unknown. Immunocytochemical studies have identified that primary sensory nerve fibers distribute throughout the cardiovascular system especially in the resistance arteries ( Fig.  1 ) [5] , suggesting that these nerves may be involved in the regulation of cardiovascular homeostasis. Capsaicin, isolated from hot pepper by Thresh in 1846 [6] , leads to excitation of a subpopulation of primary sensory neurons with somata in dorsal root ganglion (DRG) or trigeminal ganglion [7] . The primary sensory neurons excited by capsaicin include unmyelinated C-and myelinated Afibers, which have been described as capsaicin-sensitive sensory neurons given that sensitivity to capsaicin is a common trait shared by these neurons. Once excited, electrical signals are generated in these nerves and sent to the central nervous system. Simultaneously, independent of conducted electrical impulses, the efferent function of these nerves would allow the release of vasoactive sensory neuropeptides including calcitonin gene-related peptide (CGRP) and substance P from their peripheral nerve endings [7] leading to potent vasodilation in many vascular beds [8] .
The effects of capsaicin are mediated by binding and activating the transient receptor potential vanilloid type 1 (TRPV1) channel or the vanilloid receptor 1 (VR1), which belongs to the transient receptor potential (TRP) superfamily of ion channels [9] . This receptor, primarily expressed in capsaicin-sensitive sensory neuron and nerve fibers, contains six transmembrane domains with a re-entrant pore separating the last two domains [9, 10] . It has been suggested that the TRPV1 receptor functions as a molecular integrator of painful chemical and physical stimuli including capsaicin, noxious heat, and low pH [11] . The fact that activation of the TRPV1 expressed in sensory neurons leads to release of a number of potent cardiovascular modulators from nerve endings indicates that this receptor may play a key role in regulation of cardiovascular homeostasis.
In 1977, it was reported that an appropriate dose of capsaicin given to new-born rats sacrificed the majority of small-to medium-sized DGR neurons [12] . The finding was further confirmed by Nagi et al. [13] showing that treatment of neonatal rats with capsaicin leads to a permanent destruction of up to 90% of peripheral unmyelinated afferent fibers, an event possibly linked with deprivation of sensory nerves with nerve growth factor [14] . Since then, neonatal capsaicin treatment has been used for identifying the role of capsaicinsensitive sensory nerves in pathphysiological regulatory processes. Based on this model, we discovered for the first time that neonatal degeneration of sensory nerves induced by capsaicin treatment (Fig. 2) renders a rat to respond to a salt load with a significant and sustained rise in blood pressure (Fig. 3) [15] . This model provides a novel experimental paradigm for exploring the mechanisms linked with increased salt sensitivity of arterial pressure and sensory nerve function.
This review focuses on reviewing the current knowledge regarding the possible role of sensory nerves in regulating blood pressure homeostasis as well as the interaction between sensory nerves and neuro-hormonal systems controlling blood pressure, including the sympathetic nervous system, the renin-angiotensin system, endothelin, and oxidative stress. Moreover, putative endogenous agonists of the TRPV1 and perspectives of drug development are also discussed.
Fig. (2).
Visualization by immunohistochemistry of calcitonin gene-related peptide-like immunoreactivity in the mesenteric artery of an adult rat neonatally treated with capsaicin (50 mg/kg, sc). Note that CGRP-positive sensory nerve fibers in the mesenteric artery of this capsaicin-treated rat are remarkably less than in that of the control rat shown in Fig. (1) .
CAPSAICIN-SENSITIVE SENSORY NERVES AND SALT-SENSITIVE HYPERTENSION
Accumulating evidence suggests that capsaicin-sensitive sensory nerves and their neurotransmitters are intimately involved in the pathogenesis of hypertension. The effects of these nerves and their neurotransmitters are either direct or mediated by interacting with the sympathetic nervous system and vasoactive agents derived from the vasculature and the kidney. We reported in 1998 that neonatal treatment with capsaicin resulted in an elevation of blood pressure in rats fed a high salt diet but not in rats fed a normal salt diet (Fig.  3) [15] . Increased blood pressure in sensory denervated rats fed a high salt diet was accompanied by a decease in water and sodium excretion, suggesting the impairment in renal function in the face of salt challenge in this model. These results are supported by reports from Kopp et al. [16] who have shown that disruption of afferent renal nerves with surgical intervention impairs urinary sodium excretion and increases blood pressure in rats fed a high salt diet. These results are also consistent with the early reports by Burg et al. [17] , showing that selective depletion of spinal substance P and CGRP in afferent renal nerves with intrathecal administration of capsaicin enhanced the development of onekidney renal wrap hypertension. These findings provide the evidence supporting that afferent renal nerves are important in preventing salt-induced increases in blood pressure. Likewise, Manzini and Bacciarelli [18] found that, in the deoxycorticosterone acetate (DOCA)-salt hypertensive model, hypertension was of quicker onset and of greater magnitude in the rats pretreated with capsaicin, indicating that capsaicin-sensitive sensory nerves may constitute one of antihypertensive mechanisms to prevent development of DOCA-salt hypertension. Indeed, the studies by Supowit et al. [19] reported that bolus injection of CGRP , a CGRP receptor antagonist, produced a dose-dependent increase in mean arterial pressure in DOCA-salt hypertensive rats, suggesting that CGRP released by sensory nerves plays a protective role in preventing the development of hypertension in this model.
THE SYMPATHETIC NERVOUS SYSTEM
The cardiovascular tissues and the kidney are richly innervated by post-ganglionic sympathetic fibers. In the kidney, sympathetic nerves innervate the afferent and efferent renal arterioles, juxtaglomerular apparatuses, proximal renal tubules, loops of Henle, and renal distal tubules [20, 21] . Therefore, the efferent renal sympathetic nerves may affect the function of the renal vasculature, renin release, and sodium and water excretion [22, 23] . Evidence exists suggesting that the sympathetic nervous system may serve as initiating as well as sustaining mechanisms responsible for elevated arterial pressure in experimental animals and humans. In a number of experimental models of hypertension including spontaneously hypertensive [24, 25] and DOCA-salt hypertensive rats [26] and essential hypertensive humans [27, 28] , there is an increase in sympathetic nerve activity, which appears to contribute significantly to the development of hypertension through modulation of renal vascular resistance and urinary sodium excretion.
Traditionally, the role of the sensory nervous system in the regulation of sympathetic outflow has been thought to be mediated via baroreflex mechanisms. It has become apparent recently that somatic capsaicin-sensitive sensory nerves and their neuropeptides exert a regulatory influence on sympathetic nerve activity. The DRG contains cell bodies of CGRP-positive neurons, which send axons to peripheral tissues (i.e., hearts, blood vessels and kidneys) and centrally to laminae I/II of the dorsal horn of the spinal cord. These afferents synapse with the intermediolateral cell column of the spinal cord, which contains the sympathetic preganglionic neurons. This connection provides morphological evidence supporting that primary afferents may influence sympathetic nerve activity at the level of the spinal cord, and thus regulate cardiovascular function (Fig. 4) . Likewise, evidence shows that CGRP may modulate sympathetic nervous activity centrally or at the peripheral sites. Fisher et al. [29] Fig. (4). Schematic illustration of neural control of cardiovascular function and blood pressure. In addition to classic baroreflexes, sensory nerves activated by mechanical or chemical stimuli transmit electrical signals to the central nervous system and release sensory neurotransmitters, which, in coordination with the sympathetic nervous system, regulate cardiovascular function. PVG, paravertebral chain ganglia; MCG, middle cervical ganglion; ARG, aorticorenal ganglion; DRG, dorsal root ganglia; CGRP, calcitonin gene-related peptide; SP, substance P; NKA, neurokinin A.
reported that intracerebroventricular administration of CGRP enhanced sympathetic nerve activity and increased blood pressure, suggesting that CGRP acts in the central nervous system to stimulate noradrenergic sympathetic outflow. In contrast, the studies by Ralevic and Takenaga et al. [30, 31] have shown that vasoconstriction in response to adrenergic nerve stimulation is potentiated significantly by capsaicininduced denervation of sensory nerves or by blockade of the CGRP receptor with CGRP 8-37 administered into perfused mesenteric vascular beds, suggesting that CGRP suppresses Fig. (3) . Systolic blood pressure in vehicle (CON) or capsaicin (CAP)-treated rats fed a normal (NS, 0.5% of sodium) or high (HS, 4% of sodium)-sodium diet for 14 days. Systolic blood pressure was measured by the tail-cuff method in the conscious state on day 14. Neonatal rats received vehicle (5% ethanol, 5% Tween-80 and 90% saline) or CAP (50 mg/kg, dissolved in 5% ethanol, 5% Tween-80 and 90% saline) on the first and second days of life. Values are mean ± SE (n = 6-8 rats). *P<0.05 versus CON-NS, CON-HS, and CAP-NS.
adrenergic nerve-induced vasoconstriction via both prejunctional and postjunctional mechanisms. Several studies have shown that genetic deletion of CGRP leads to increased blood pressure associated with elevated sympathetic nervous activity [32, 33] . These results provide evidence supporting that CGRP inhibits sympathetic nerve activity. Further studies are necessary to clarify the mechanisms responsible for CGRP-induced inhibition of sympathetic nerve activity.
We found that sympathectomy produced by administration of guanethidine prevented the development of saltsensitive hypertension induced by sensory nerve degeneration [34] . The finding suggests that enhanced sympathetic nerve activity may contribute to the increase in blood pressure in capsaicin-pretreated rats fed a high salt diet, and that capsaicin-sensitive sensory nerves may normally inhibit sympathetic nerve activity, especially during high salt intake. We also found, however, that blockade of the 1 -adrenoceptor with prazosin was not effective in preventing the development of salt-induced hypertension in capsaicinpretreated animals [35] . The reasons for the ineffectiveness of prazosin in decreasing blood pressure in the later study are unknown, but may be due to: (1) the dose of prazosin used was not high enough to decrease blood pressure in this model, even though the same dose caused reduction in blood pressure in spontaneously hypertensive rats [36] ; (2) 1 -adrenoceptors were necessary for the development of saltsensitive hypertension, a possibility supported by findings of Osborn et al. [37] showing that blockade of the 1 -adrenoceptor with prazosin renders rats salt-sensitive and leads to the development of salt-sensitive hypertension; and (3) the sympathetic nervous system might contribute to the development of salt-sensitive hypertension in neonatally capsaicinpretreated rats via a non-1 -adrenoceptor mechanisms.
THE RENIN-ANGIOTENSIN-ALDOSTERONE SYS-TEM
Pressure natriuresis is a key component to regulate the body fluid volume. In all forms of hypertension, there is a shift of renal pressure natriuresis that requires increased arterial pressure to maintain sodium and water balance [38, 39] . The renin-angiotensin system (RAS) is a powerful hormone system regulating blood pressure and body fluid volumes, as evidenced by the effectiveness of various RAS blockers in reducing arterial pressure and protecting against cardiovascular and renal injury in many forms of hypertension [40] . In most conditions, activation of the RAS occurs as a compensatory response to volume depletion or circulatory depression. These actions help to return body fluid volumes and arterial pressure toward normal levels. Angiotensin II (Ang II), the effector of the RAS, produces antinatriuretic actions via increasing renal tubular reabsorption rather than reducing glomerular filtration rate (GFR), except in pathophysiological conditions in which Ang II contributes to glomerulosclerosis and loss of nephron function. Ang II increases tubular reabsorption by direct as well as indirect effects such as stimulation of aldosterone [41] to decrease sodium excretion to very low levels. The long-term effects of the RAS on blood pressure are closely intertwined with volume homeostasis through direct and indirect actions on renal excretory function. The mechanisms responsible for regulation of the body fluid volume contribute to long-term blood pressure regulation. Inappropriately high Ang II levels reduce renal excretory function and impair pressure natriuresis, thereby necessitating increased arterial pressure to maintain sodium balance [41, 42] . In addition, Ang II stimulates the synthesis of preproendothelin [43] and produces oxidative stress [44] . Thus, in addition to its direct effects, activation of the RAS may stimulate the production of endothelin and oxidative stress to further increase blood pressure.
We explored the role of the RAS in the development of salt-sensitive hypertension induced by neonatal sensory denervation [35] . Losartan, a type 1 Ang II receptor antagonist, was given to capsaicin-pretreated rats fed a high salt diet. We found that systolic blood pressure and mean arterial pressure were higher in capsaicin-treated rats fed a high salt diet compared to capsaicin-treated rats fed a high salt diet plus losartan or hydralazine, a nonspecific vasodilator. Although losartan and hydralazine decreased blood pressure, these drugs did not improve the impaired natriuretic response to salt load in capsaicin-pretreated rats [35] . These results suggest that losartan and hydralazine may lower blood pressure via direct vasodilatory mechanisms, rather than those that improve the impairment of urinary sodium and water excretion. These findings suggest but not provide proofs for an interaction between capsaicin-sensitive sensory nerves and the RAS. The interaction between these two systems was further investigated in Ang II-induced hypertensive rats, and the results showed that sensory denervation by capsaicinpretreatment exacerbated the development of hypertension induced by subpressor infusion of Ang II [45] . Moreover, we found that sensory denervation in subpressor Ang II-infused rats resulted in a decrease in water and sodium excretion [45] , a result that was different from unchanged sodium and water balance in animals treated with small or subpressor doses of Ang II alone [45, 46] . These findings suggest that capsaicin-sensitive sensory nerve innervation preserves the renal excretory function in hypertension induced by subpressor infusion of Ang II. The notion is supported by the evidence showing that renal nerves promote sodium excretion in hypertension induced by Ang II infusion [47] . These studies provide a rationale for future investigation of sensory nerve control of the renal function under pathophysiological conditions. Plasma renin activity and plasma aldosterone level are significantly higher in sensory-denervated rats fed a high diet compared to sensory nerve-intact rats fed a high salt diet [48] . To define the influence of altered aldosterone levels, spironolactone, a selective aldosterone receptor antagonist, was given to capsaicin-pretreated rats fed a high salt diet. We found that spironolactone normalized blood pressure and renal excretory function in capsaicin-pretreated rats fed a high salt diet [48] . These data indicate that the circulating renin-angiotensin-aldosterone system is insufficiently suppressed by salt load in sensory-denervated rats, resulting in an increase in salt sensitivity in terms of blood pressure regu-lation. It is well established that aldosterone increases the reabsorption of sodium and the secretion of potassium by regulating the Na + -K + -ATP ase and epithelial Na + channels located in a variety of tissues, including collecting ducts of the kidney, sweat glands, salivary glands, and the intestine [49, 50] . Moreover, aldosterone enhances ion permeability in vascular smooth muscles and amplifies the local vasoconstrictor system, actions that have been suggested to play a role in the mineralocorticoid-salt model [51] . It is conceivable therefore that elevated aldosterone levels play a role in the development of hypertension in this model, possibly via renal dependent and independent mechanisms. Further studies are necessary to define the mechanisms underlying aldosterone action in this model.
THE ENDOTHELIN SYSTEM
The endothelin system is a family of 3 distinct 21-residue peptides, including ET-1, ET-2, and ET-3. ET-1 is synthesized by endothelial cells, and is a potent vasoconstrictor [52] . The physiological actions of ET-1 are mediated by at least two receptor subtypes including ET A and ET B receptors. The ET A receptors, expressed mainly in smooth muscle cells of blood vessels, contribute to the vasoconstriction response to ET-1 [53] . Activation of ET B receptors induced by ET-1 mediates numerous pathophysiological responses including smooth muscle contraction, vasodilation, and clearance of circulating ET-1 [53] . Moreover, ET-1 amplifies the contractile response to other vasoactive agents, including norepinephrine and serotonin [54] . Consistent with these findings, ET-1 potentiates sympathetically mediated vasoconstriction in hypertensive patients such that a positive correlation exists between ET-1-induced vasoconstriction and blood pressure [53] .
In addition to blood vessels, the kidney is one of the most sensitive organs to ET1 stimulation. ET-1 is produced in the kidney and both of its receptor subtypes, ET A and ET B, are present in the kidney [55] . Thus, ET-1 possesses potent and complex actions in the kidney, whereby it causes renal vasoconstriction and regulates renal sodium and water excretion. It is well established that ET-1 is a potent constrictor of both afferent and efferent arterioles and causes a decrease in renal blood flow and GFR, leading to a reduction in urine flow and sodium excretion [55, 56] . Both receptor subtypes have been reported to contribute to renal vasoconstriction [57] . However, activation of ET B receptors expressed in renal distal tubules causes opposite effects and promotes natriuretic and diuretic actions of ET-1 [57] .
ET-1, when administered on long-term bases, increases sodium reabsorption in the kidney and elevates blood pressure [58, 59] . It is well established that the endothelin system is activated in salt-dependent models of hypertension, including DOCA-salt hypertensive rats and genetic Dahl saltsenitive hypertensive rats [60, 61] . In these models as well as a subpopulation of hypertensive patients, plasma ET1 levels are elevated and production of ET-1 in vascular endothelial cells is enhanced [62, 63] . Consistent with these findings, endothelin receptor antagonists lower blood pressure in these models [60, 61] . These findings provide strong evidence that the endothelin system is involved in the development of hypertension.
In salt-sensitive hypertension induced by sensory nerve degeneration, we found that increased blood pressure occurred in association with an increase in plasma ET-1 levels [64] . Moreover, blockade of the ET A receptor with ABT-627, a highly selective ET A receptor antagonist, prevented the development of hypertension in this model, albeit it did not alleviate impaired renal function in capsaicin-treated rats fed a high salt diet [64] . In this study, ABT-627 was given by oral gavage twice per day, a stress leading to water and sodium retention which may offset the beneficial effect of this drug on improving renal function. Indeed, our recent studies showed that ABT-627 when given in drinking water prevents the development of hypertension and improves renal hemodynamics and excretory function in sensory nerve degenerated rats fed a high salt diet [65] . These results indicate that elevated endogenous ET-1 and subsequent activation of the ET A receptors exert antinatriuretic actions that may contribute to increased salt-sensitivity of arterial pressure in the sensory denervated model or in general.
The fact that plasma ET-1 levels are increased in sensory nerve-denervated rats fed a high salt diet suggests that capsaicin-sensitive sensory nerves and their neurotransmitters may normally inhibit the synthesis and release of ET-1 [64, 65] . In contrast, several lines of evidence indicate that ET-1 leads to a release of sensory neurotransmitters which play a compensatory role in preventing ET-1-induced elevation in blood pressure. It has been reported that CGRP acts as a compensatory vasodilator to attenuate the increase in blood pressure in DOCA-salt hypertension [19] . Increased neuronal expression of CGRP and presumably the release of this peptide suggest that circulating and/or autocrine/paracrine factors such as elevated levels of endothelin may stimulate the long-term synthesis and release of CGRP from sensory afferents in DOCA-salt hypertension [60, 62] . Indeed, Gokin et al. [66] reported that peripheral administration of ET-1 induces nocifensive behavior that is reversible by administration of an ET A receptor antagonist, suggesting that ET A receptors are present in sensory afferent fibers. This view is further supported by studies from Pomonis et al., showing that ET A receptor-immunoreactivity is found in CGRPcontaining sensory neurons in DRG, whereas ET B receptorimmunoreactivity is observed in DRG satellite cells or Schwann cells [67] . The fact that colocalization of ET A and CGRP in sensory nerve fibers supports the notion that ET-1-induced CGRP release is mediated by activation of the ET A receptor. Moreover, recent studies from our laboratory have shown that, in addition to ET B receptor-mediated vasodilation, chronic infusion of ET-1 at the pathophysiological concentration leads to an ET A -dependent CGRP release, which may play a counterregulatory role in preventing ET-1-induced increases in blood pressure [68] .
Although salt-sensitive hypertension induced by sensory nerve degeneration is characterized by an increase in plasma ET-1 levels, the mechanisms responsible for elevated ET-1 levels are unclear. It has been reported that ET B receptors are involved in ET-1 clearance [57] . However, elevated plasma ET-1 levels in sensory denervated rats fed a high salt diet were unaffected by blockade of the ET B receptors [64] , suggesting that 1) the elevated plasma ET-1 levels are not mediated by the ET B receptors; or 2) ET B receptors are downregulated in sensory denervated rats leading to ineffectiveness in blockade of the ET B with its antagonists. Moreover, it is known that the endothelin system can be upregulated by Ang II [43] , and ET A receptors have been shown to mediate Ang II-induced hypertension in animal studies [69] . Likewise, endothelin causes oxidative stress, and endothelin production has been shown to be increased in response to oxidative stress [70] . Therefore, elevated plasma endothelin levels in this model could be the result of increases in Ang II and/or oxidative stress.
REACTIVE OXYGEN SPECIES
Several lines of evidence indicate that oxidative stress plays an important role in cardiovascular dysfunction, including ischemic heart disease, chronic heart failure, and diabetes mellitus. Oxidative stress is a state in which excess reactive oxygen species (ROS) overwhelm endogenous antioxidant systems. Superoxide (O 2 ·-), formed by the univalent reduction of oxygen, is one of the most important ROS affecting the cardiovascular system [71] . Potential sources of vascular superoxide production include NAD(P)H-dependent oxidases, xanthin oxidase, lipoxygenase, mitochondrial oxidase, and NO synthases [71] . NAD(P)H oxidases appear to be the principal source of superoxide production in several animal models of vascular disease [44, 72] . This is due to the fact that NAD(P)H oxidase protein abundantly expresses in the cardiovascular system [73] , and is responsive to a variety of agonists, such as angiotensin and endothelin-1 [44, 74] .
ROS has been implicated in the development of hypertension and other pathologic processes including ischemic heart disease and chronic heart failure, effects involving inactivation of NO by superoxide in the vasculature and the kidney and H 2 O 2 -induced vessel modeling. ROS is increased in several hypertensive models including spontaneously hypertensive rats, 2-kidney, 1-clip hypertensive rats, Ang IIinfused hypertensive rats, DOCA-salt hypertensive rat, and Dahl salt-sensitive hypertensive rats [75] [76] [77] [78] [79] . Furthermore, administration of antioxidants, cell-permeable superoxide dismutase (SOD) mimetic tempol, or genetic deletion of NAD(P)H oxidase partially normalizes blood pressure in these models of hypertension [75] [76] [77] [78] [79] [80] . These observations strongly suggest that ROS contributes to the onset and maintenance of hypertension.
We found that salt-sensitive hypertension induced by sensory nerve degeneration is associated with an increase in superoxide production and a compensatory elevation in MnSOD levels in mesenteric resistant arteries, indicating that ROS is increased in this salt-sensitive hypertensive model [81] . The mechanisms responsible for the increase in ROS are unclear. As discussed above, plasma ET-1 levels are increased and the renin-angiotensin-aldosterone system is insufficiently inhibited in sensory denervated rats fed a high salt diet [48, 64, 65] . It is well-established that Ang II and ET-1 stimulate superoxide formation via activating NAD(P)H oxidases [44, 74] . Therefore, the increase in superoxide production may be derived from activation of the ET and Ang II systems in this model. Although our findings suggest that ROS may contribute to the development of salt-sensitive hypertension induced by sensory nerve degeneration, treatment with tempol is ineffective in lowering blood pressure in this model [81] . This is in contrast to the effect of membrance-targeted forms of SOD and other antioxidants on blood pressure in hypertension [75] [76] [77] [78] [79] . Although it is unclear why tempol is unable to lower blood pressure in this model, there are alternative explanations for these results: 1) the influence of tempol on blood pressure wanes over time; 2) tempol is ineffective in lowering superoxide production and in improving renal function even though superoxide production in mesenteric arteries is inhibited by tempol; and 3) as an SOD mimetic, tempol converts superoxide to hydrogen peroxide (H 2 O 2 ) that is subsequently converted to H 2 O by catalase and glutathione peroxide (GPx). It is possible that tempol leads to more H 2 O 2 production in the kidney than that can be handled by the endogenous H 2 O 2 -scavenging systems. It has been reported that chronic increases in H 2 O 2 levels in the renal medulla result in hypertension [82] . Moreover, the studies by Michael et al. [83] indicate that increased renal H 2 O 2 levels may limit the ability of tempol to lower blood pressure in salt-sensitive hypertension. Further studies are necessary to clarify the role of increased superoxide in the development of hypertension in sensory-denervated rats fed a high salt diet.
TRPV1 RECEPTORS AND ANANDAMIDE
Anandamide, isolated from porcine brain in 1992 [84] , is one of the endogenous ligands for the cannabinoid (CB) receptor. Cannabinoids are known to elicit neurobehavioral as well as cardiovascular effects. The biological effects of cannabinoids are mediated by specific receptors, of which two subtypes have been identified by molecular cloning. The CB1 receptors express abundantly in both the central nervous system and peripheral tissues [85] , whereas CB2 receptor expression is restricted to the immune system [86] . Given their profound cardiovascular effects in humans and animals, there is ever-increasing interest in endogenous cannabinoids. Recent studies show that anandamide and its analogs cause a prolonged hypotension and bradycardia in anesthetized normotensive rats, rats fed a high salt diet, or spontaneously hypertensive rats (SHR) [87] [88] [89] . Despite the potent cardiovascular effects, relatively little is known about the mechanisms underlying anandamide-induced cardiovascular actions. CB1 receptors have been found in the nucleus of the solitary tract and in the dorsal motor nucleus of the vagus [90] , suggesting that CB1 expressed in the brain may be involved in the regulation of cardiovascular function. In addition, accumulating evidence shows that cannabinoids presynaptically inhibit the release of noradrenaline from postganglionic sympathetic neurons [91] . Therefore, cannabinoids may influence cardiovascular function via modulating autonomic outflow in both the central and peripheral sites.
The studies by Varga et al. have shown that anandamideinduced prolonged hypotension is attenuated by pretreatment with cervical spinal transection or by -adrenoceptor and cannabinoid receptor antagonists, indicating that the sympathetic nerve system may be involved in the depressor response [92] . Moreover, it is evident that there is no centrally elicited effect of anandamide on the firing rate of presympathetic sympathoexcitatory neurons in the rostral ventrolateral medulla oblongata and of splanchnic sympathetic nerve fibers [87] . These results suggest that peripheral actions of anandamide appear to be predominating in cardiovascular regulation.
Recently, several lines of evidence in vitro and in vivo have shown that anandamide-induced cardiovascular actions may be mediated by its activation of the TRPV1 receptor [88, 89, 93] . Several studies report that anandamide displays a highly structural similarity to the vanilloids [94, 95] . The studies by Zygmunt et al. [93] demonstrate that anandamide and its analogue methanandamide (MethA) act as agonists at the recombinant rat TRPV1 receptors. These findings are further confirmed by Smart et al. using the human TRPV1 clone [96] . Furthermore, Wagner et al. [97] have demonstrated that SR141716A, a selective CB1 receptor antagonist, fails to inhibit anandamide-induced vasodilation in endothelium-denuded mesenteric preparations from rats. This study suggests that anandamide-induced mesenteric vasodilation is partially mediated by an SR-141716A-resistant action on vascular smooth muscle. Zygmunt and colleagues [93] demonstrate that in isolated rat hepatic, rat mesenteric, and guinea pig basilar arterial preparations, anandamide-induced relaxation is almost completely blocked either by the selective TRPV1 receptor antagonist, capsazepine (CAPZ), or by the selective CGRP receptor antagonist, CGRP 8-37, but not by SR141617A. These results suggest that the TRPV1-mediated release of CGRP from sensory nerves is responsible for the anandamide-evoked vasorelaxation. In animal studies, we have demonstrated that the MethA-induced depressor effect in SHR rats is attenuated by blockade of the TRPV1 receptor with CAPZ, indicating that activation of the TRPV1 receptor is involved in anandamide-induced hypotensive effects [89] . Moreover, the latest studies from our laboratory have shown that plasma anandamide concentrations are increased during high sodium intake (unpublished data), and that MethA causes an enhanced and dose-dependent depressor effect in high salt-treated rats which can be attenuated by a TRPV1 receptor antagonist [88] . These findings support the concept that activation of the TRPV1 receptor induced by endogenous anandamide may play a compensatory role in attenuating the increase in blood pressure during high sodium intake.
CLINICAL RELEVANCE AND CONCLUSION
It is estimated that 65 million individuals in the United States suffer from hypertension. High salt intake has been implicated in the pathogenesis of hypertension, particularly in salt-sensitive individuals [2] . Studies in salt-dependent experimental animals and humans have shown that high salt intake is associated with significant increases in blood pressure [3] . The mechanisms underlying salt-sensitive hypertension, however, remain poorly understood. There is accumulating evidence showing that a defect in the sensory nervous system exists in Dahl salt-sensitive hypertensive and spontaneously hypertensive rats [98, 99] . The Dahl salt-sensitive model is believed to best approximate the pathology associated with hypertension in African Americans [100, 101] . It is conceivable that sensory nerve dysfunction may contribute to the development of hypertension in these models of hypertension. Given that the sensory nervous system, including TRPV1 receptors expressed in sensory nerves, sensory neurotransmitters, and their receptors, plays a counter regulatory role in attenuating salt-induced increases in blood pressure [15, 88] , it is reasonable to speculate that agents that modulate activity of the sensory nervous system may be beneficial in treating hypertension as well as in reducing the long-term complications resulting from hypertension. It is well established that TRPV1 is activated by the plant extract capsaicin. Moreover, capsaicin produces a profound hypotensive effect in SHR and in rats fed a high salt diet, suggesting that activation of the TRPV1 may be an efficacious means in preventing the development of hypertension [88, 89] . Clinically, repeated topical applications of cream containing capsaicin are effective for the relief of chronic pain including postherpetic neuralgia and neuropathy [102, 103] . These inhibitory actions of topical capsaicin are thought to be primarily due to functional desensitization of nociceptive neurons. Systemic applications of capsaicin in humans are rare due to the irritant nature of this exogenous compound. However, of growing interest is the compelling evidence that TRPV1 receptors expressed in sensory nerves may be activated by an array of endogenous molecules including anandamide and other lipid metabolites [88, 89, 93] . In light of the fact that high sodium intake increases anandamide levels as well as the depressor response to exogenous anandamide [88] , we propose that anandamide may serve as an endovanilloid compound able to stimulate TRPV1 leading to prevention of salt-induced increases in blood pressure. It follows that manipulations modulating anandamide production or metabolism may alter TRPV1 function and therefore blood pressure. Our results may provide a rationale for the search of novel endogenous and/or exogenous TRPV1 agonists and antagonists for the treatment of salt-dependent hypertension and may improve our understanding of the molecular mechanisms leading to increased salt sensitivity especially in diverse ethnic groups.
